ICU日记联合作业治疗对重症患者精神认知障碍发生率的影响研究

注册号:

Registration number:

ChiCTR2200063671 

最近更新日期:

Date of Last Refreshed on:

2022-09-14 19:07:16 

注册时间:

Date of Registration:

2022-09-14 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

ICU日记联合作业治疗对重症患者精神认知障碍发生率的影响研究

Public title:

The effect of ICU diary combined with occupational therapy on the incidence of mental cognitive impairment in severe patients

注册题目简写:

English Acronym:

研究课题的正式科学名称:

基于OP模式的ICU日记联合作业治疗对重症患者精神认知障碍发生率的影响研究

Scientific title:

The effect of ICU diary based on the occupational performance combined with occupational therapy on the incidence of mental cognitive impairment in severe patients

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

李定艮 

研究负责人:

杨永红 

Applicant:

Dinggen Li 

Study leader:

Yonghong Yang 

申请注册联系人电话:

Applicant telephone:

13550399601

研究负责人电话:

Study leader's
telephone:

18980602263

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

799976442@qq.com

研究负责人电子邮件:

Study leader's E-mail:

nicole308@126.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

四川省成都市武侯区国学巷37号

研究负责人通讯地址:

四川省成都市武侯区国学巷37号

Applicant address:

No. 37 Guoxue Xiang, Chengdu, Sichuan 610041, P. R. China

Study leader's address:

No. 37 Guoxue Xiang, Chengdu, Sichuan 610041, P. R. China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

四川大学华西医院

Applicant's institution:

West China Hospital, Sichuan University

研究负责人所在单位:

Affiliation of the Leader:

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

1670

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

四川大学华西医院生物医学伦理审查委员会

Name of the ethic committee:

Ethics Committee on Biomedical Research,West China Hospital of Sichuan University

伦理委员会批准日期:

Date of approved by ethic committee:

2022-01-26 00:00:00

伦理委员会联系人:

彭淑贤

Contact Name of the ethic committee:

Shuxian Peng

伦理委员会联系地址:

四川省成都市武侯区国学巷37号第八教学楼413办公室

Contact Address of the ethic committee:

Office 413, Eighth Teaching Building, 37 Guoxue Lane, Chengdu, Sichuan Province, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

028-85423237

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

四川大学华西医院

Primary sponsor:

West China Hospital, Sichuan University

研究实施负责(组长)单位地址:

四川省成都市武侯区国学巷37号

Primary sponsor's address:

No. 37 Guoxue Xiang, Chengdu, Sichuan 610041, P. R. China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

四川

市(区县):

Country:

China

Province:

Sichuan

City:

单位(医院):

四川大学华西医院

具体地址:

四川省成都市武侯区国学巷37号

Institution
hospital:

West China Hospital, Sichuan University

Address:

No. 37 Guoxue Xiang, Chengdu, Sichuan 610041, P. R. China

经费或物资来源:

Source(s) of funding:

no

研究疾病:

重症监护室患者  

Target disease:

Patients of Intensive Care Unit

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

I期临床试验 

Study phase:

1

研究设计:

非随机对照试验 

Study design:

Non randomized control 

研究目的:

1. 主要目的 探讨ICU作业日记对ICU患者的谵妄、创伤后应激综合征(PTSD)、焦虑和抑郁等精神认知障碍发生的影响 2. 次要目的 探讨ICU 作业日记对患者在ICU住院时间、日常生活活动能力和生活质量的影响。  

Objectives of Study:

1. Main objective: to investigate the effect of ICU work diary on the occurrence of delirium, post-traumatic stress syndrome (PTSD), anxiety, depression and other mental cognitive disorders in ICU patients 2. Secondary objective: to explore the effects of ICU operation diary on the length of ICU stay, ability of daily living activities and quality of life.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

1)严重痴呆症或急性或亚急性严重神经功能障碍或损伤;
2)严重精神疾病(不包括抑郁症)或发育问题;
3)疑似或确诊的药物或酒精中毒/过量或戒断阶段;
4)未纠正的或严重的听力或视力障碍;
5)心脏骤停后昏迷和/或低温治疗;
6)主治医生或医疗团队拒绝;

Exclusion criteria:

1) Severe dementia or acute or subacute severe neurological dysfunction or injury;
2) Serious mental illness (excluding depression) or developmental problems;
3) Suspected or confirmed drug or alcohol poisoning/overdose or withdrawal stage;
4) Uncorrected or severe impairment of hearing or vision;
5) Coma and/or hypothermia after cardiac arrest;
6) Refusal by the attending doctor or medical team;

研究实施时间:

Study execute time:

From 2022-07-04 00:00:00 To 2023-09-14 00:00:00  

征募观察对象时间:

Recruiting time:

From 2022-09-14 00:00:00 To 2023-09-14 00:00:00

干预措施:

Interventions:

组别:

试验组

样本量:

87

Group:

Experimental group

Sample size:

干预措施:

作业治疗+日记

干预措施代码:

Intervention:

occupational therapy+diary

Intervention code:

组别:

对照组

样本量:

87

Group:

Control group

Sample size:

干预措施:

常规康复治疗

干预措施代码:

Intervention:

conventional rehbbilitation

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

四川 

市(区县):

 

Country:

China

Province:

Sichuan

City:

单位(医院):

四川大学华西医院 

单位级别:

三甲 

Institution
hospital:

West China Hospital, Sichuan University

Level of the institution:

测量指标:

Outcomes:

指标中文名:

重症监护室患者谵妄评估

指标类型:

主要指标

Outcome:

CAM-ICU

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

镇静水平评估

指标类型:

主要指标

Outcome:

RASS

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

事件影响量表评估

指标类型:

主要指标

Outcome:

Impact Event Scale-Revised questionnaire

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

医院焦虑抑郁量表

指标类型:

主要指标

Outcome:

Hospital Anxiety and Depression Scale

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

日常生活活动能力

指标类型:

次要指标

Outcome:

Ability of daily life activities

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

生活质量评估

指标类型:

次要指标

Outcome:

SF-36

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

汉化重症监护室记忆评估工具

指标类型:

次要指标

Outcome:

ICU Memory Tool

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

ICU住院时间

指标类型:

次要指标

Outcome:

Length of stay in ICU

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

no

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 85 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

由第三方使用Excel表格进行随机数字分组

Randomization Procedure (please state who generates the random number sequence and by what method):

Use Excel tables to randomization

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

no

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

no

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

no

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2022-09-14 19:07:07